Investing Profile

Nina Kjellson

VCInvestor
General Partner at Canaan Partners
canaan.com/team/nina-kjellsonMenlo Park, California
Photo of Nina Kjellson, General Partner at Canaan Partners
Your Intro Paths to Nina Kjellson

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Nina Kjellson on

cb
Current Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
33
Current Fund Size
$800M

Nina Kjellson is on these Sector & Stage Rankings

Nina Kjellson's Investments On Record (18)

CompanyStageDateRound SizeTotal Raised
Actio Biosciences
Series ASep 2023$55M
$55M
Co-investors: Jason Fuller (Deerfield Management)
Rondo Therapeutics
Series AMar 2022$67M
$67M
Co-investors: Jon Edwards (Red Tree Venture Capital)
Vineti
Series COct 2020$33M
Series CFeb 2020$35M
Series BApr 2018$34M
$100M
Co-investors: Mike Pellini (Section 32), Marc Benioff
Dauntless Pharmaceuticals
Series AFeb 2017$25M
$37M
Co-investors: David Kabakoff (HealthQuest Capital)
Welltok
Series EOct 2016$34M
Series DJan 2015$37M
Series CFeb 2014$22M
Series BApr 2013$19M
$240M
Co-investors: Kevin Spain (Emergence Capital), Blake Wu (New Enterprise Associates (NEA)), Mohamad Makhzoumi (New Enterprise Associates (NEA)), Lily Huang (New Enterprise Associates (NEA)), Bruce Hallett (Miramar Ventures), Michael Greeley (Flare Capital Partners), Sharon Stevenson (Okapi Venture Capital)
Eiger BioPharmaceuticals
Debt FinancingMar 2016
Series AApr 2011$15M
Series AApr 2011$14M
Series AFeb 2009$8M
$37M
Co-investors: Edgar Engleman (Vivo Capital)
TESARO
Post Ipo EquityMar 2016$160M
Series BJun 2011$100M
$320M
Co-investors: Sara Nayeem (Avoro Ventures), Beth Seidenberg (Westlake Village BioPartners), Scott Weiner (Amzak Health Investors)
Tizona Therapeutics
Series BMar 2016$43M
$43M